MedTrace Logo

Effectiveness of a Short, Intensive and Standardised Spa Therapy for Low Back Pain on Sick Leave Duration

NCT01648738 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2018-01-08

No results posted yet for this study

Summary

The purpose of this study is to determine whether an intensive 5 days long multidisciplinary program (including spa therapy, exercises and patients'education) is more effective regarding return to work than usual care in subacute and chronic low back pain for people in sick leave from 4 to 24 weeks duration, and for which an extension of sick leave is considered

Conditions

  • Low Back Pain

Interventions

OTHER

Spa therapy, exercise and educational therapy

During 5 days: Spa therapy (2 hours/day), exercises (30 min/day), educational therapy (45 min/day) including education on physical activities, work, and pain management

OTHER

Usual care

Information, counseling, treatment usually provided for sub-acute and chronic low back pain and the back book

Sponsors & Collaborators

  • Association Francaise pour la Recherche Thermale

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Serge POIRAUDEAU, MD PhD · Cochin Hospital and Descartes University, INSERM

  • Emmanuel COUDEYRE, MD, PhD · University Hospital, Clermont-Ferrand

  • Arnaud DUPEYRON, MD, PhD · Groupe Hospitalo-Universitaire Carémeau

  • Ygal ATTAL, MD

  • Jean-Max TESSIER, MD · Hôpital Thermal de Dax

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2015-12-31
Completion
2016-04-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01648738 on ClinicalTrials.gov